Cephalon's Double Trouble: DoJ Probes Treanda Marketing, Clinical Trial Data

The inquiry comes three years after the company settled a government investigation of off-label marketing of three other drugs.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet